Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Goodwill (2020 - 2025)

Historic Goodwill for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $129.4 million.

  • Maravai Lifesciences Holdings' Goodwill fell 2465.86% to $129.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.4 million, marking a year-over-year decrease of 2465.86%. This contributed to the annual value of $159.9 million for FY2024, which is 5096.2% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Goodwill stood at $129.4 million, which was down 2465.86% from $129.4 million recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Goodwill peaked at $326.6 million during Q1 2023, and registered a low of $8.8 million during Q1 2025.
  • For the 5-year period, Maravai Lifesciences Holdings' Goodwill averaged around $230.2 million, with its median value being $283.5 million (2022).
  • Its Goodwill has fluctuated over the past 5 years, first surged by 8566.75% in 2022, then crashed by 9730.09% in 2025.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Goodwill stood at $152.8 million in 2021, then soared by 85.67% to $283.7 million in 2022, then increased by 14.92% to $326.0 million in 2023, then plummeted by 50.96% to $159.9 million in 2024, then fell by 19.05% to $129.4 million in 2025.
  • Its Goodwill stands at $129.4 million for Q3 2025, versus $129.4 million for Q2 2025 and $8.8 million for Q1 2025.